Sign in
4

Changes in Ownership

Altimmune, Inc. Filed Acc 0001104659-22-007911

Director acquired 70 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Drutz David · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-01-25 Exercise or conversion : show line 1 in the form +70 $2.40 $168 17,882 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-01-25 Exercise or conversion : show line 2 in the form Stock Options (option to buy) −70 69 D
Loading xslF345X03/tm224587-1_4.xml…